Pharmaceuticals
Defensible governance for the pharmaceutical sector
Pharma companies are held to the highest standards in clinical compliance. Datamaran brings that same rigor to governance, giving you the real-time intelligence you need to mitigate risk and make decisions you can stand behind.
Trusted by leading companies worldwide
Industry challenges
Why pharma companies face intense regulatory and reputational pressure
Across pharmaceuticals, biotech, and medical devices, companies face the same pressures: regulation that outpaces internal tracking, non-financial performance now tied directly to investor and market trust, and risk data too fragmented to defend under scrutiny.
Complex Regulatory Landscape
With regulations evolving across countries, pharma companies face mounting pressure to track and respond to compliance requirements before they become costly violations.
Reputational and Investor Scrutiny
Non-financial performance is increasingly tied to investment decisions and public trust. Gaps in disclosure or governance can expose pharma companies to significant financial and reputational risk.
Fragmented Risk Data
External risk data is often siloed across departments, making it difficult to build a coherent, audit-ready strategy that satisfies both leadership and external stakeholders.
Solution
A clear view of the global emerging risk landscape
Datamaran helps pharma and life science companies identify priority issues, stay ahead of regulatory change, benchmark strategy, and build defensible disclosures. With AI-powered analytics, risk intelligence, and cross-functional workflows, that deliver a structured approach that strengthens governance and decision-making.
Regulatory Monitoring
Identify compliance risks before they impact your business
Track regulatory changes across 190+ countries
Monitor CSRD, SEC climate disclosure rules, and pharma-specific mandates in real time to prevent compliance gaps.
Understand governance issues across R&D and manufacturing
Stay on top of emerging regulations affecting patient safety, supply chain ethics, and workforce standards before they become problems.
Build audit-ready regulatory governance
Ensure every regulatory signal is logged, tracked, and managed, and is ready for board or assurance review.
Core
Run materiality assessments that stand up to scrutiny
Quantify regulatory and reputational risks
Connect compliance mandates, patient safety, and workforce governance directly to your materiality assessment and overall risk picture.
Automate materiality for complex pharma operations
Run evidence-based assessments across global operations without the need for manual spreadsheets or consultants.
Align non-financial risks with enterprise risk registers
Give your colleagues and C-suite a traceable, audit-ready view of what's material across your full value chain.
Suite
Benchmark priorities against pharma sector peers
Compare risks against leading life sciences and pharma companies
See how peers are disclosing net-zero targets, supply chain governance, and patient access commitments.
Pinpoint reporting gaps before external auditors do
Identify where your disclosures fall short of sector norms and regulatory expectations.
Set credible targets based on industry evidence
Ground climate and governance targets in what leading pharma companies are actually committing to.
Customer spotlight
How Organon built a data-backed ESG strategy
With increasing scrutiny from investors, regulators, and consumers on ESG topics, Organon needed to develop an ESG strategy fast. Using Datamaran, it carried out a materiality analysis to identify priority risks and issues, and now relies on the platform for always-on intelligence that supports executive decisions.
140
Markets covered by the materiality assessment
10-K
Insights used to support Organon's filings
Why pharma companies choose Datamaran
Continuous risk monitoring
Replace periodic reviews with always-on intelligence across 190+ countries.
Defensible data trails
Every materiality decision is traceable, documented, and audit-ready.
Colleague and C-suite alignment
Surface ESG priorities as structured risk intelligence for leadership and board teams.
Scalable across operations
From a single market to a global portfolio, Datamaran scales with your business.
